GlaxoSmithKline Consumer Healthcare has received an approval from the Competition Commission of India (CCI) for its merger deal with Hindustan Unilever (HUL).
The scheme remains subject to the receipt of other necessary statutory and regulatory approvals under applicable laws, including by the NSE, SSE, SEBI, NCLT and the respective shareholders and creditors of HUL and the company.
Glaxosmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks.